Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice

Kidney International

Volumn 66, Issue 4, 2004, Pages 1393-1402

  Mühlfeld, Anja S ^b   Spencer, Min W ^b   Hudkins, Kelly L ^b   Kirk, Elizabeth ^b   LeBoeuf, Renee C ^b   Alpers, Charles E ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b NONE

Author keywords

Extracellular matrix; Hyperlipidemia; ROP Os +

Indexed keywords

CYTOKINE; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE EXACERBATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HYPERLIPIDEMIA; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY MASS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; UREA NITROGEN BLOOD LEVEL;

EID: 4644325687     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00854.x     Document Type: Article

References (53)

1. MITCH WE, WALSER M, BUFFINGTON GA, et al: A simple method of estimating progression of chronic renal failure. Lancet 2:1326-1328, 1976
2. WILLIAMS PS, FASS G, BONE JM: Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med 67:343-354, 1988
3. NOVICK AC, GEPHARDT G, GUZ B, et al: Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 325:1058-1062, 1991
4. SOLOMON LR, MALLICK NP, LAWLER W: Progressive renal failure in a remnant kidney. Br Med J (Clin Res Ed) 291:1610-1611, 1985
5. PRAVTCHEVA DD, WISE TL: A postimplantation lethal mutation induced by transgene insertion on mouse chromosome 8. Genomics 30:529-544, 1995
6. PRAVTCHEVA DD, WISE TL: A transgene-induced mitotic arrest mutation in the mouse allelic with oligosyndactylism. Genetics 144:1747-1756, 1996
7. ZALUPS RK: The Os/+ mouse: A genetic animal model of reduced renal mass. Am J Physiol 264:F53-F60, 1993
8. HE C, ZALUPS RK, HENDERSON DA, et al: Molecular analysis of spontaneous glomerulosclerosis in Os/+ mice, a model with reduced nephron mass. Am J Physiol 269:F266-F273, 1995
9. ESPOSITO C, HE CJ, STRIKER GE, et al: Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol 154:891-897, 1999
10. ZHENG F, STRIKER GE, ESPOSITO C, et al: Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int 54:1999-2007, 1998
11. MASCHIO G, OLDRIZZI L, RUGIU C, et al: Serum lipids in patients with chronic renal failure on long-term, protein-restricted diets. Am J Med 87:51N-54N, 1989
12. SAMUELSSON O, AURELL M, KNIGHT-GIBSON C, et al: Apolipoprotein-B- containing lipoproteins and the progression of renal insufficiency. Nephron 63:279-285, 1993
13. SASAKI T, KURATA H, NOMURA K, et al: Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus. Jpn J Med 29:156-163, 1990
14. SHOJI T, NISHIZAWA Y, TOYOKAWA A, et al: Decreased albuminuria by pravastatin in hyperlipidemic diabetics. Nephron 59:664-665, 1991
15. RABELINK AJ, HENE RJ, ERKELENS DW, et al: Partial remission of nephrotic syndrome in patient on long-term simvastatin. Lancet 335:1045-1046, 1990
16. SEGERER S, HUDKINS KL, TANEDA S, et al: Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis. Am J Kidney Dis 39:876-888, 2002
17. HUGO C, SHANKLAND SJ, BOWEN-POPE DF, et al: Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. J Clin Invest 100:786-794, 1997
18. HIROMURA K, HASELEY LA, ZHANG P, et al: Podocyte expression of the CDK-inhibitor p57 during development and disease. Kidney Int 60:2235-2246, 2001
19. SEGERER S, EITNER F, CUI Y, et al: Cellular injury associated with renal thrombotic microangiopathy in human immunodeficiency virus-infected macaques. J Am Soc Nephrol 13:370-378, 2002
20. TANEDA S, HUDKINS KL, CUI Y, et al: Growth factor expression in a murine model of cryoglobulinemia. Kidney Int 63:576-590, 2003
21. ALPERS CE, HUDKINS KL, PRITZL P, et al: Mechanisms of clearance of immune complexes from peritubular capillaries in the rat. Am J Pathol 139:855-867, 1991
22. ALPERS CE, HUDKINS KL, GOWN AM, et al: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41:1134-1142, 1992
23. DING G, PESEK-DIAMOND I, DIAMOND JR: Cholesterol, macrophages, and gene expression of TGF-beta 1 and fibronectin during nephrosis. Am J Physiol 264:F577-F584, 1993
24. DING G, VAN GOOR H, FRYE J, et al: Transforming growth factor-beta expression in macrophages during hypercholesterolemic states. Am J Physiol 267:F937-F943, 1994
25. SCHREYER SA, WILSON DL, LEBOEUF RC: C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136:17-24, 1998
26. JIMI S, UESUGI N, SAKU K, et al: Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli. Arterioscler Thromb Vasc Biol 19:794-801, 1999
27. WATANABE Y, OZAKI I, YOSHIDA F, et al: A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis. Nephron 51:265-270, 1989
28. KASISKE BL, O'DONNELL MP, SCHMITZ PG, et al: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37:880-891, 1990
29. JOLES JA, KUNTER U, JANSSEN U, et al: Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 11:669-683, 2000
30. GUIJARRO C, KASISKE BL, KIM Y, et al: Early glomerular changes in rats with dietary-induced hypercholesterolemia. Am J Kidney Dis 26:152-161, 1995
31. AL-SHEBEB T, FROHLICH J, MAGIL AB: Glomerular disease in hypercholesterolemic guinea pigs: A pathogenetic study. Kidney Int 33:498-507, 1988
32. YOSHIMURA N, ARIMA S, NAKAYAMA M, et al: Renal impairment and intraglomerular mononuclear phagocytes in cholesterol-fed rabbits. Nephron 68:473-480, 1994
33. KAMANNA VS, KIRSCHENBAUM MA: Association between very-low-density lipoprotein and glomerular injury in obese Zucker rats. Am J Nephrol 13:53-58, 1993
34. WEN M, SEGERER S, DANTAS M, et al: Renal injury in apolipoprotein e-deficient mice. Lab Invest 82:999-1006, 2002
35. CORITSIDIS G, RIFICI V, GUPTA S, et al: Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 39:858-866, 1991
36. WASSERMAN J, SANTIAGO A, RIFICI V, et al: Interactions of low density lipoprotein with rat mesangial cells. Kidney Int 35:1168-1174, 1989
37. WHEELER DC, CHANA RS, TOPLEY N, et al: Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int 45:1628-1636, 1994
38. NISHIDA Y, ODA H, YORIOKA N: Effect of lipoproteins on mesangial cell proliferation. Kidney Int 56(Suppl 71):S51-S53, 1999
39. ROVIN BH, TAN LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43:218-225, 1993
40. KIM SB, KANG SA, CHO YJ, et al: Effects of low density lipoprotein on type IV collagen production by cultured rat mesangial cells. Nephron 67:327-333, 1994
41. LAMARCHE B, DESPRES JP, MOORJANI S, et al: Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol 75:1189-1195, 1995
42. GRUNDY SM: Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 106:2526-2529, 2002
43. PURCELL-HUYNH DA, FARESE RV, JR., JOHNSON DF, et al: Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J Clin Invest 95:2246-2257, 1995
44. ATTMAN PO, ALAUPOVIC P, SAMUELSSON O: Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease. Kidney Int 56(Suppl 71):S14-S17, 1999
45. SAMUELSSON O, MULEC H, KNIGHT-GIBSON C, et al: Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 12:1908-1915, 1997
46. SAMUELSSON O, ATTMAN PO, KNIGHT-GIBSON C, et al: Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol 9:1482-1488, 1998
47. HATTORI M, NIKOLIC-PATERSON DJ, MIYAZAKI K, et al: Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury. Kidney Int 56(Suppl 71):S47-S50, 1999
48. KODAMA N, OTANI H, YAMADA Y, et al: Involvement of MCP-1 and M-CSF in glomerular foam cell formation in ExHC rats. Kidney Int 56(Suppl 71):S174-S177, 1999
49. MIYAZAKI K, ISBEL NM, LAN HY, et al: Up-regulation of macrophage colony-stimulating factor (M-CSF) and migration inhibitory factor (MIF) expression and monocyte recruitment during lipid-induced glomerular injury in the exogenous hypercholesterolaemic (ExHC) rat. Clin Exp Immunol 108:318-323, 1997
50. LAVAUD S, MICHEL O, SASSY-PRIGENT C, et al: Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model. J Am Soc Nephrol 7:2604-2615, 1996
51. PESEK-DIAMOND I, DING G, FRYE J, et al: Macrophages mediate adverse effects of cholesterol feeding in experimental nephrosis. Am J Physiol 263:F776-F783, 1992
52. MATSUDA S, ARAI T, IWATA K, et al: A high-fat diet aggravates tubulointerstitial but not glomerular lesions in obese Zucker rats. Kidney Int 56(Suppl 71):S150-S152, 1999
53. SHANKLAND SJ, JOHNSON RJ: TGF-beta in glomerular disease. Miner Electrolyte Metab 24:168-173, 1998